Xin-mei Huo
Beijing, 100191, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
ADR, an optimized combination of ASIV, DLA, and R1, ameliorates blood-brain barrier disruption following rtPA thrombolysis at 4.5 h after stroke onset in mice via multitarget regulation.
Journal: Journal of advanced research
Published: September 11, 2025
YangXue QingNao Wan ameliorates vascular dementia in 2-VO rats via inhibition of ferroptosis.
Journal: Journal of ethnopharmacology
Published: May 14, 2025
Qing-Fei-Pai-Du-Tang ameliorates lipopolysaccharide-induced rat acute lung injury through attenuating pulmonary microcirculatory disturbances via multi-target regulation.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 05, 2024
Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4.
Journal: Frontiers in pharmacology
Published: April 22, 2024
YangXueQingNaoWan attenuated blood brain barrier disruption after thrombolysis with tissue plasminogen activator in ischemia stroke.
Journal: Journal of ethnopharmacology
Published: June 15, 2023
Xihuang pill ameliorates colitis in mice by improving mucosal barrier injury and inhibiting inflammatory cell filtration through network regulation.
Journal: Journal of ethnopharmacology
Published: May 25, 2023
Yu-Ping-Feng Formula Ameliorates Alveolar-Capillary Barrier Injury Induced by Exhausted-Exercise via Regulation of Cytoskeleton.
Journal: Frontiers in pharmacology
Published: March 08, 2022
Real-time observation of nucleoplasmin-mediated DNA decondensation and condensation reveals its specific functions as a chaperone.
Journal: Biochimica et biophysica acta. Gene regulatory mechanisms
Published: April 25, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026